Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting

The purpose of this study is to evaluate the risk of hepatitis B reactivation in patients undergoing allografting.

Completed

Looking for future studies?

Key information

Conditions

Hepatitis B Virus Allograft Blood-Borne Infections Communicable Diseases DNA Virus Infections Digestive System Diseases Hematologic Diseases Hematologic Neoplasms Hematological Malignancies Hemic and Lymphatic Diseases Hepadnaviridae Infections Hepatitis Hepatitis B Hepatitis, Viral, Human Infections Liver Diseases Neoplasms Neoplasms by Site Virus Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Azienda ospedaliera S Giovanni Battista

Torino, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients undergoing an allograft for hematological malignancies

Sponsors and collaborators

Lead sponsor

Azienda Ospedaliera San Giovanni Battista

Other

Registry information

Important dates

First posted: Apr 6, 2009
Registry last updated: Apr 6, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed